Chloroquine

Generic Name
Chloroquine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H26ClN3
CAS Number
54-05-7
Unique Ingredient Identifier
886U3H6UFF
Background

Chloroquine is an aminoquinolone derivative first developed in the 1940s for the treatment of malaria. It was the drug of choice to treat malaria until the development of newer antimalarials such as pyrimethamine, artemisinin, and mefloquine. Chloroquine and its derivative hydroxychloroquine have since been repurposed for the treatment of a number of other c...

Indication

Chloroquine is indicated to treat infections of P. vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. It is also used to treat extraintestinal amebiasis.
...

Associated Conditions
Discoid Lupus Erythematosus (DLE), Extraintestinal Amebiasis, Malaria, Polymorphic Light Eruption (PLE), Porphyria Cutanea Tarda, Rheumatoid Arthritis, Sarcoidosis, Acute, uncomplicated Malaria
Associated Therapies
-

Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance

Not Applicable
Completed
Conditions
First Posted Date
2005-09-01
Last Posted Date
2017-01-12
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
700
Registration Number
NCT00140517
Locations
🇧🇫

Centre Medicale Paul VI, Ouagadougou, Burkina Faso

Chloroquine and Amodiaquine for Treatment of Malaria in Children

Phase 4
Completed
Conditions
First Posted Date
2005-08-30
Last Posted Date
2008-04-08
Lead Sponsor
Bandim Health Project
Target Recruit Count
720
Registration Number
NCT00137514
Locations
🇬🇼

Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau

Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda

Not Applicable
Completed
Conditions
First Posted Date
2005-08-22
Last Posted Date
2017-01-12
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
2548
Registration Number
NCT00132535
Locations
🇺🇬

Uganda AIDS Commission, Kampala, Uganda

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

Phase 3
Completed
Conditions
First Posted Date
2005-08-19
Last Posted Date
2017-01-12
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
900
Registration Number
NCT00131703

Antimalarial Drug Resistance in Mali

Not Applicable
Completed
Conditions
First Posted Date
2005-08-09
Last Posted Date
2006-08-16
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1011
Registration Number
NCT00127998
Locations
🇲🇱

Koro Health Center, Koro, Mali

🇲🇱

Faladje Missionary Dispensary, Faladje, Mali

🇲🇱

Pongono Community Health Center, Pongono, Mali

Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

Phase 2
Terminated
Conditions
First Posted Date
2004-05-14
Last Posted Date
2011-04-26
Lead Sponsor
Pfizer
Target Recruit Count
14
Registration Number
NCT00082563
© Copyright 2024. All Rights Reserved by MedPath